<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00438191</url>
  </required_header>
  <id_info>
    <org_study_id>2005-P-002319</org_study_id>
    <nct_id>NCT00438191</nct_id>
  </id_info>
  <brief_title>A Clinical Trial of Splinting for DeQuervain's Tenosynovitis</brief_title>
  <official_title>A Clinical Trial of Full Time vs. As Needed Splint Wear for DeQuervain's Tenosynovitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <brief_summary>
    <textblock>
      DeQuervain's tenosynovitis is characterized by pain on the pain on the radial (thumb) side of
      the wrist problems with thumb function. At this point, the standard care is to change daily
      activities, use a thumb brace, and the possible use of painkillers. There is a difference in
      opinion among physical therapists about how to use the splint in the treatment of DeQuervain
      tenosynovitis. Some physicians tell patients to wear the brace at all times while other
      therapists encourage patients to exercise and use the brace as needed. Both approaches to
      using the splint are accepted as standard. The purpose of this study is to test and evaluate
      these two ways of splinting and assess which one is better for patients with DeQuervain
      tenosynovitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      De Quervain's tenosynovitis (stenosing tenosynovitis of the first dorsal extensor
      compartment) is characterized by pain on the radial (thumb) side of the wrist and impairment
      of thumb and wrist function. Histological evaluation is consistent with a chronic rather than
      an acute tenosynovitis consistent with the often prolonged course of this disease.

      Nonoperative treatments include modification of activities, splint immobilization, icing and
      anti-inflammatory medication, and corticosteroid injections. Long opponens splinting (or
      short arm thumb spica splinting; a splint that immobilizes the wrist and the thumb) is
      standard and well accepted. There is no consensus on the best protocol for use of the splint.
      Some authors advocate full time splinting for 4 - 6 weeks, with the rationale that tendonitis
      will resolve with strict rest. Other authors, perhaps aware of histological evidence that De
      quervain's is a chronic rather than acute inflammatory condition, feel that the splint serves
      merely to relieve symptoms and is best used as best suits each individual patient. To our
      knowledge, there are not data available regarding these disparate views.

      The ultimate prognosis for recovery in the condition seems satisfying, regardless of the
      treatment, and spontaneous recovery is the rule. Psychological and personality factors, such
      as pain anxiety, catastrophizing, and depression are strongly related to upper extremity
      specific health status and may also influence recovery.

      The primary goal of this study is to determine which protocol of splinting leads to better
      outcome in non-surgical treatment of DeQuervain's tenosynovitis. As a secondary goal and to
      generate hypotheses for later studies we would like to evaluate the influence of psychosocial
      factors on both objective (grip strength) and subjective (DASH questionnaire) measures of
      outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>The DASH questionnaire measures upper extremity disability on a scale from 0-100, where 0 is no disability and 100 is severe disability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Grip Strength</measure>
    <time_frame>8 weeks</time_frame>
    <description>Grip strength is measured as a percentage of the non-affected or least affected side.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>8 weeks</time_frame>
    <description>Treatment satisfaction was measured on a scale from 0-10, where 0 is complete dissatisfaction and 10 is complete satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">83</enrollment>
  <condition>DeQuervain's Tenosynovitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Subjects who wear the splint whenever the feel the need.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Subjects who wear the splint whenever possible.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the MGH Hand and Upper Extremity Service.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient (age 18 years or greater)

          -  Physician very confident about the diagnosis of DeQuervain's tenosynovitis.

        Exclusion Criteria:

          -  Patients with previous history of surgical treatment for De Quervain's.

          -  Skin conditions making splint wear problematic.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Ring, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2007</study_first_submitted>
  <study_first_submitted_qc>February 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2007</study_first_posted>
  <results_first_submitted>February 2, 2017</results_first_submitted>
  <results_first_submitted_qc>April 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 20, 2017</results_first_posted>
  <last_update_submitted>April 6, 2017</last_update_submitted>
  <last_update_submitted_qc>April 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David C. Ring, MD</investigator_full_name>
    <investigator_title>Principal Investigator; Director of Research, Hand Service</investigator_title>
  </responsible_party>
  <keyword>DeQuervain's tenosynovitis</keyword>
  <keyword>splinting</keyword>
  <keyword>grip strength</keyword>
  <keyword>satisfaction</keyword>
  <keyword>DASH questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenosynovitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>As-Desired Splinting</title>
          <description>Subjects who wear the splint as desired</description>
        </group>
        <group group_id="P2">
          <title>Full Time Splinting</title>
          <description>Subjects who wear the splint as much as possible</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>As-Desired Splinting</title>
          <description>Subjects who wear the splint as desired</description>
        </group>
        <group group_id="B2">
          <title>Full Time Splinting</title>
          <description>Subjects who wear the splint as much as possible</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="83"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.93" spread="14.58"/>
                    <measurement group_id="B2" value="48.74" spread="13.90"/>
                    <measurement group_id="B3" value="49.26" spread="14.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire</title>
          <description>The DASH questionnaire measures the upper extremity disability on a scale from 0-100, 0 is no disability and 100 is the most disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.5" spread="19.0"/>
                    <measurement group_id="B2" value="33.3" spread="17.8"/>
                    <measurement group_id="B3" value="34.96" spread="18.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain Intensity</title>
          <description>Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.5" spread="2.3"/>
                    <measurement group_id="B2" value="5.8" spread="2.4"/>
                    <measurement group_id="B3" value="5.6" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Center for Epidemiologic Studies Depression Scale - Revised (CES-D)</title>
          <description>The CESD-R measures symptom of depression in nine different groups. The range of possible scores is between 0 (for those who say ‘not at all or less than one day to all 20 questions) and 60 (nearly everyday for 2 weeks for all 20 questions).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.3" spread="6.5"/>
                    <measurement group_id="B2" value="16.3" spread="8.7"/>
                    <measurement group_id="B3" value="16.3" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain Catastrophizing scale (PCS)</title>
          <description>The Pain Catastrophizing Scale measures a set of mal-adaptive cognitive conditions while in pain. The score ranges from 0-52, ranging from least to most catastrophic thinking.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.9" spread="8.7"/>
                    <measurement group_id="B2" value="17.5" spread="9.5"/>
                    <measurement group_id="B3" value="19.3" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Grip Strength</title>
          <description>Grip strength measured as a percentage of the non-affected hand.</description>
          <units>percentage of non-affected hand</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.1" spread="22.9"/>
                    <measurement group_id="B2" value="58.6" spread="18.7"/>
                    <measurement group_id="B3" value="56.3" spread="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire</title>
        <description>The DASH questionnaire measures upper extremity disability on a scale from 0-100, where 0 is no disability and 100 is severe disability.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>As-Desired Splinting</title>
            <description>Subjects who wear the splint as desired</description>
          </group>
          <group group_id="O2">
            <title>Full Time Splinting</title>
            <description>Subjects who wear the splint as much as possible</description>
          </group>
        </group_list>
        <measure>
          <title>Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire</title>
          <description>The DASH questionnaire measures upper extremity disability on a scale from 0-100, where 0 is no disability and 100 is severe disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" spread="15"/>
                    <measurement group_id="O2" value="29" spread="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Grip Strength</title>
        <description>Grip strength is measured as a percentage of the non-affected or least affected side.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>As-Desired Splinting</title>
            <description>Subjects who wear the splint as desired</description>
          </group>
          <group group_id="O2">
            <title>Full Time Splinting</title>
            <description>Subjects who wear the splint as much as possible</description>
          </group>
        </group_list>
        <measure>
          <title>Grip Strength</title>
          <description>Grip strength is measured as a percentage of the non-affected or least affected side.</description>
          <units>percentage of non-affected hand</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" spread="25"/>
                    <measurement group_id="O2" value="87" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Satisfaction</title>
        <description>Treatment satisfaction was measured on a scale from 0-10, where 0 is complete dissatisfaction and 10 is complete satisfaction</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>As-Desired Splinting</title>
            <description>Subjects who wear the splint as desired</description>
          </group>
          <group group_id="O2">
            <title>Full Time Splinting</title>
            <description>Subjects who wear the splint as much as possible</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Satisfaction</title>
          <description>Treatment satisfaction was measured on a scale from 0-10, where 0 is complete dissatisfaction and 10 is complete satisfaction</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="2.6"/>
                    <measurement group_id="O2" value="6.4" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity</title>
        <description>Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>As-Desired Splinting</title>
            <description>Subjects who wear the splint as desired</description>
          </group>
          <group group_id="O2">
            <title>Full Time Splinting</title>
            <description>Subjects who wear the splint as much as possible</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity</title>
          <description>Pain intensity was measured using the Numeric Rating Scale, on a scale from 0-10, where 0 is no pain and 10 is the most pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="2.0"/>
                    <measurement group_id="O2" value="4.4" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>As-Desired Splinting</title>
          <description>Subjects who wear the splint as desired</description>
        </group>
        <group group_id="E2">
          <title>Full Time Splinting</title>
          <description>Subjects who wear the splint as much as possible</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Taylor Pong</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <email>tpong1@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

